Cytokeratin fragments in the serum: Their utility for the management of oral cancer
Authors:
- Surekha M. ZingdeSZSurekha M. Zingde
- Milind M. VaidyaMVMilind M. Vaidya
- 1 August 2008
- journal article
- review article
- Published by Elsevier in Oral Oncology
- Vol. 44 (8) , 722-732
Abstract
No abstract availableKeywords
This publication has 107 references indexed in Scilit:
- New consensus nomenclature for mammalian keratinsJournal of Cell Biology, 2006
- Method validation and preliminary qualification of pharmacodynamic biomarkers employed to evaluate the clinical efficacy of an antisense compound (AEG35156) targeted to the X-linked inhibitor of apoptosis protein XIAPBritish Journal of Cancer, 2006
- Evaluation of urine CYFRA 21‐1 for the detection of primary and recurrent bladder carcinomaCancer, 2002
- Viewing apoptosis through a ‘TUNEL’The Journal of Pathology, 2001
- The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancerInternational Journal of Gynecological Cancer, 2001
- CYFRA 21-1 determination in patients with esophageal squamous cell carcinomaCancer, 2000
- Epitope Specificity of 30 Monoclonal Antibodies against Cytokeratin Antigens: The ISOBM TD5-1 WorkshopTumor Biology, 1998
- CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluationEuropean Journal of Cancer, 1994
- Increased expression of cytokeratins 8, 18 and vimentin in the invasion front of mucosal squamous cell carcinomaThe Journal of Pathology, 1993
- Aberrant expression of the simple epithelial type II keratin 8 by mouse skin carcinomas but not papillomasMolecular Carcinogenesis, 1992